ChemicalBook Chinese Germany Japanese Korean

廊坊市恒福源医药科技有限公司 Company Information
Company Name:    LangFangshi Hengfuyuan Pharma Tech CO.,Itd.
Tel:    0316-2883536
Email:    1877241811@qq.com
Nationality:    China
WebSite:    www.zkhfychem.com/
Product List:    2071
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Product List
Osimertinib Impurity 21 2213409-62-0
Benzofuran-6-carboxylicacid(LifitegrastImpurity) 77095-51-3
Osimertinib Impurity 19 1421373-33-2
Osimertinib Impurity 15 1421373-34-3
Celecoxib Carboxylic Acid 170571-01-4
Telmisartan Impurity 10 136304-93-3
diethyl 2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-dicarboxylate 144690-53-9
Osimertinib Impurity 16 1421373-31-0
1,4-Benzenediamine, 5-methoxy-N1,N1-dimethyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitro- 1820891-36-8
Vonoprazan Impurity 10 2169271-28-5
Lifitegrast Impurity 8 2271299-08-0
Irbesartan Impurity 14 133690-91-2
Lifitegrast Impurity 7 2129597-34-6
diethyl 2-propylimidazoledicarbonate 144689-94-1
2-Pyrimidinamine, N-(2,4-dimethoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)- 1942853-78-2
1-Piperazinecarboxylic acid, 4-[3-methoxy-4-[[2-[[3-[(1-oxo-2-propen-1-yl)amino]phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-, 1,1-dimethylethyl ester 2120319-14-2
Losartan EP Impurity B 160514-13-6
Vonoprazan Impurity 14 1807642-39-2
Irbesartan Impurity 3 152708-24-2
Osimertinib Impurity 22 1421372-34-0
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate 1194550-67-8
Vonoprazan Impurity 1885094-63-2
methyl (S)-2-(5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl) propanoate hydrochloride 2758051-12-4
Vonoprazan Impurity 312307-69-0
2-Propenamide, N-[3-[[4-[[4-(4-acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]phenyl]- 1888303-01-2
TAK438 Impurity 112 2932441-73-9
2982988-09-8
Celecoxib Impurity 30 53764-99-1
Gluconic acid 526-95-4
Celecoxib Impurity A 170570-01-1
Celecoxib Impurity F 170569-99-0
DMDO 37830-90-3
Osimertinib Impurity 23 1421373-99-0
Olmesartan Medoxomil Impurity 25;2-propyl-1H-imidazole-4,5-dicarboxylic acid 144690-04-0
(R)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoic acid 1270132-45-0
Vonoprazan Impurity X Fumaric acid 928325-82-0
Olmesartan 144689-24-7
Piracetam 7491-74-9
Olmesartan Impurity 52 58954-23-7
1H-Imidazole-4-carboxylic acid, 5-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 1048948-20-4
5,7-dichloro-1,2,3,4-tetrahydroisoquinoline 89315-56-0
Isoquinoline, 5,7-dichloro-1,2,3,4-tetrahydro-2-(triphenylmethyl)- 1289646-72-5
Boc-3-(Methylsulfonyl)-L-Phenylalanine 1289646-76-9
GLYCINE ANHYDRIDE 106-57-0
Vonoprazan Impurity 1883595-37-6
5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole 124750-53-4
Lifitegrast Impurity 26 2295862-29-0
Lifitegrast Impurity 28 2982988-08-7
Osimertinib Impurity 29 2408329-87-1
Irbesartan Impurity 15 154709-19-0
4,4,4-Trifluoro-1-(p-tolyl)-1,3-butanedione 720-94-5
1548527-26-9
Celecoxib iMpurity-G 1061214-06-9
2-(tert-butoxycarbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid 851784-82-2
Osimertinib Impurity 14 1421373-32-1
1,3-Benzenediamine, 4,6-dimethoxy-N1-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]- 1942853-79-3
N-(2-(dimethylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide 2044702-39-6
ifitegrast impurity C 851785-70-1
2'-(Triphenylmethyltetrazol-5-yl)biphenyl-4-yl]carboxaldehyde;Olmesartan Impurity 81 155983-56-5
Celebrex P 921617-76-7
Osimertinib Impurity 11 1975982-94-5
Benzenesulfonamide, 4-[2-(1-phenylethylidene)hydrazinyl]- 1135952-91-8
(2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol 154709-18-9
oxiracetam impurity III 62833-66-3
Olmesartan Medoxomil Impurity E 144689-23-6
benzyl (S)-2-amino-3-(3-(methylsulfonyl)phenyl)propanoate 1194550-59-8
Vonoprazan Impurity D 881674-58-4
Osimertinib Impurity 30 1421373-36-5
2(1H)-Isoquinolinecarboxylic acid, 5,7-dichloro-3,4-dihydro-6-[[[(1S)-1-[[3-(methylsulfonyl)phenyl]methyl]-2-oxo-2-(phenylmethoxy)ethyl]amino]carbonyl]-, 1,1-dimethylethyl ester 1194550-61-2
4,4,4-Trifluoro-1-phenyl-1,3-butanedione 326-06-7
(4-ETHOXY-2-OXO-2,5-DIHYDRO-PYRROL-1-YL)-ACETIC ACID 142274-08-6
Lifitegrast Impurity 51 2177264-60-5
2-Propenamide, N-[2,4-dimethoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- 1942853-18-0
Osimertinib Impurity 17 2227103-37-7
oxiracetam impurity VI 85614-52-4
4'-(azidomethyl)-[1,1'-biphenyl]-2-carboxylic acid 2758005-15-9
Irbesartan Impurity 24 2763750-28-1
4-hydroxypyrrolidin-2-one 25747-41-5
Vonoprazan Impurity U9 1885094-62-1
Osimertinib Impurity 18 1801616-92-1
2(1H)-Isoquinolinecarboxylic acid, 5,7-dichloro-3,4-dihydro-, 1,1-dimethylethyl ester 2215846-47-0
oxiracetam impurity IV 77191-37-8
Olmesartan Medoxomil Impurity 32 1040405-56-8
Lifitegrast Impurity 3 1194550-65-6
6-Isoquinolinecarboxylic acid, 5,7-dichloro-1,2,3,4-tetrahydro-, hydrochloride 1289646-93-0
Osimertinib Impurity 20 1801616-73-8
ethyl benzofuran-6-carboxylate；Lifitegrast Impurity 32 1289646-90-7
Vonoprazan Impurity 1831110-76-9
Osimertinib Impurity 13 1421373-35-4
Osimertinib Impurity 12 1932710-29-6
2-Propenamide, N-[3-[[2-[[2-methoxy-4-(1-piperazinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]- 2763827-03-6
Celecoxib Impurity 3 170569-87-6
oxiracetaM related substance ISF3886 120428-80-0
2'-(1H-Tetrazol-5-yl)-1,1'-biphenyl-4-carboxaldehyde (Losartan IMpurity) 151052-40-3
Lifitegrast Impurity 15 2049127-88-8
Osimertinib Impurity I 2044702-55-6
2(e),4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityltetraazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester 1203671-69-5
oxiracetam impurity VII 62613-81-4
Ethanone, 1-[4-[4-[[2-[(3-aminophenyl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]-3-methoxyphenyl]-1-piperazinyl]- 2044703-15-1
Celecoxib Impurity 17 2247197-65-3
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Copyright 2007©  ChemicalBook. All rights reserved.